Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA EXPORT REGULATIONS SHOULD BE CHANGED LEGISLATIVELY TO REDUCE MANUFACTURING FLIGHT OVERSEAS, AMGEN CHAIRMAN BINDER TELLS HOUSE OVERSIGHT SUBCOMMITTEE

Executive Summary

Elimination of FDA export restrictions via the legislative process would help reduce the relocation of U.S. manufacturing facilities overseas, Amgen Chairman Gordon Binder maintained at a May 25 House Commerce/Oversight Subcommittee hearing on FDA reform.
Advertisement
Advertisement
UsernamePublicRestriction

Register

PS026263

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel